Skip to content

Determinants and mediating mechanisms of quality of life and disease-specific symptoms among thyroid cancer patients: the WaTCh study

Determinants and mediating mechanisms of quality of life and disease-specific symptoms among thyroid cancer patients: the WaTCh study - The WaTCh study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON54712
Enrollment
400
Registered
2018-12-05
Start date
2020-08-17
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer thyroid carcinoma

Interventions

None listed

Sponsors

Universiteit van Tilburg
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Thyroid cancer population In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Diagnosed with thyroid cancer - 18 years or older - Able to fill out questionnaires in Dutch Norm population In order to be eligible for participation in this study, a participant must meet all of the following criteria: - 18 years or older - Able to fill out questionnaires in Dutch - Live near one of the WaTCh-hospitals for blood draw

Exclusion criteria

Exclusion criteria: TC patients: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Patients with cognitive impairment will not be included because of expected difficulties in completing these questionnaires without assistance. - Patients who are not able to read or write Dutch will be excluded, as they are not able to complete a Dutch questionnaire. Norm population: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Participants with cognitive impairment will not be included because of expected difficulties in completing the questionnaire without assistance (already not included in the LISS panel). - Participants who are not able to read or write Dutch will be excluded, as they are not able to complete a Dutch questionnaire (already not included in the LISS panel). - Participants with a (previous) diagnosis of a carcinoma, except for basal cell carcinoma of the skin. - Participants who have a household member already included in this study, to ensure independence of answers.

Design outcomes

Primary

MeasureTime frame
QoL and disease-specific symptoms over time.

Secondary

MeasureTime frame
fatigue, sleep, physical activity, anxiety, depression, health care utilisation, and employment.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)